| Psychosocial predictors of medication non-adherence in pediatric organ transplantation: A systematic review |
12 |
| Pediatric marginal donor hearts: Trends in US national use, 2005-2014 |
12 |
| A prospective randomized, controlled trial of eculizumab to prevent ischemia-reperfusion injury in pediatric kidney transplantation |
11 |
| Kidney transplant practice patterns and outcome benchmarks over 30 years: The 2018 report of the NAPRTCS |
9 |
| Association of post-transplant donor-specific HLA antibody with liver graft fibrosis during long-term follow-up after pediatric liver transplantation |
8 |
| Anellovirus loads are associated with outcomes in pediatric lung transplantation |
7 |
| Variability in donor selection among pediatric heart transplant providers: Results from an international survey |
7 |
| Live vaccines after pediatric solid organ transplant: Proceedings of a consensus meeting, 2018 |
7 |
| Predicting ideal outcome after pediatric liver transplantation: An exploratory study using machine learning analyses to leverage Studies of Pediatric Liver Transplantation Data |
6 |
| Pediatric intestinal transplantation: Analysis of the intestinal transplant registry |
6 |
| Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma |
6 |
| Psychosocial functioning in pediatric heart transplant recipients and their families |
6 |
| Epidemiology and outcome of chronic high Epstein-Barr viral load carriage in pediatric kidney transplant recipients |
6 |
| A systematic review of immunosuppressant adherence interventions in transplant recipients: Decoding the streetlight effect |
6 |
| Ofatumumab in post-transplantation recurrence of a pediatric steroid-resistant idiopathic nephrotic syndrome |
6 |
| A randomized clinical trial of age and genotype-guided tacrolimus dosing after pediatric solid organ transplantation |
5 |
| The impact of donor/recipient age difference and HLA mismatch on graft outcome in pediatric kidney transplantation |
5 |
| Behavioral health care in solid organ transplantation in a pediatric setting |
5 |
| Successful nivolumab therapy in an allogeneic stem cell transplant child with post-transplant lymphoproliferative disorder |
5 |
| Alternative methods for virtual heart transplant-Size matching for pediatric heart transplantation with and without donor medical images available |
4 |
| Combined liver-kidney transplantation for primary hyperoxaluria type I in children: Single Center Experience |
4 |
| Should more donation after cardiac death livers be used in pediatric transplantation? |
4 |
| Evolution of renal function and urinary biomarker indicators of inflammation on serial kidney biopsies in pediatric kidney transplant recipients with and without rejection |
4 |
| Cytomegalovirus and Epstein-Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis |
4 |
| European Society of Pediatric Nephrology survey on current practice regarding recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation |
4 |
| ABO-incompatible deceased donor pediatric liver transplantation: Novel titer-based management protocol and outcomes |
4 |
| Post-transplant lymphoproliferative disorder in pediatric intestinal transplant recipients: A literature review |
4 |
| IGG3 anti-HLA donor-specific antibodies and graft function in pediatric kidney transplant recipients |
4 |
| Outcome of children with rhinovirus detection prior to allogeneic hematopoietic cell transplant |
4 |
| Hybrid stage 1 palliation as a bridge to cardiac transplantation in patients with high-risk single ventricle physiology |
4 |
| High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality |
4 |
| Living-donor liver transplantation for mild Zellweger spectrum disorder: Up to 17years follow-up |
4 |
| Transient elastography for non-invasive evaluation of post-transplant liver graft fibrosis in children |
4 |
| Cytotoxic T-lymphocyte therapy for post-transplant lymphoproliferative disorder after solid organ transplantation in children |
4 |
| The effect of peri-transplant plasmapheresis in the prevention of recurrent FSGS |
4 |
| Prediction of mortality following pediatric heart transplant using machine learning algorithms |
4 |
| Safety and utility of surveillance biopsies in pediatric kidney transplant patients |
4 |
| The experience of combined and sequential liver and kidney transplantation from a single living donor in patients with primary hyperoxaluria type 1 |
4 |
| 20-to 25-year patient and graft survival following a single pediatric liver transplant-Analysis of the United Network of Organ Sharing database: Where to go from here |
3 |
| Use of subcutaneous treprostinil in pediatric pulmonary arterial hypertensionBridge-to-transplant or long-term treatment? |
3 |
| Outcome predictors of autologous hematopoietic stem cell transplantation in children with relapsed and refractory Hodgkin lymphoma: Single-center experience in a lower-middle-income country |
3 |
| Severe heart failure and the need for mechanical circulatory support and heart transplantation in pediatric patients with myocarditis: Results from the prospective multicenter registry MYKKE |
3 |
| The role of resilience in healthcare transitions among adolescent kidney transplant recipients |
3 |
| The impact of alternative donor types on viral infections in pediatric hematopoietic stem cell transplantation |
3 |
| Renal transplantation in children under 3 years of age: Experience from a single-center study |
3 |
| Pediatric kidney transplantation and mortality: Distance to transplant center matters |
3 |
| The role of continuous renal replacement therapy in the management of acute kidney injury associated with sinusoidal obstruction syndrome following hematopoietic cell transplantation |
3 |
| Pediatric renal transplantation: A retrospective single-center study on epidemiology and morbidity due to EBV |
3 |
| Is there an optimal organ acceptance rate for pediatric heart transplantation: A sweet spot? |
3 |
| Risk factors for persistent hyperparathyroidism in children with stable renal function after kidney transplantation |
3 |
